New version of Merck's Keytruda faces possible patent battle ... United Statescategory· February 21, 2025 US aid freeze sows disruption in HIV, malaria product supply chains The U.S ...

For the apoptosis assay, 5×10 6 cells were collected 48 hours after seeding, fixed for 20 min 2% paraformaldehyde (Merck Life Science), and for 30 ... The lysis was achieved by repeating freeze-thaw ...

All other chemicals were purchased from Merck (Darmstadt, Germany ... Equal aliquots (50 µl) of phosphate buffer 0.02 M, cell-free media, partially purified chitinase, and 5-min-boiled partially ...

The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...

In a deal that could top $1 billion, Merck & Co has teamed up with US biotech Janux Therapeutics to bring T-cell immunotherapies to cancer patients. The agreement sees San Diego-based Janux in ...

Celonic Group, a Swiss-Based Quality CDMO, is integrating Merck’s Breez micro-bioreactor platform into its process ...

This breakthrough technology involves a specialized nanoscale material that illuminates cancer cells under freezing conditions, making them easier to distinguish from healthy tissue and improving ...

The FDA has granted priority review to Merck’s supplemental Biologics License Application (sBLA) for Keytruda (pembrolizumab) as a perioperative treatment for resectable locally advanced head and neck ...

Alpha Teknova (TKNO) and Pluristyx announced that the companies are collaborating to produce and commercialize Pluristyx’s PluriFreeze product ...

(MENAFN) India's first transgender clinic, Mitr, has been shut down, as reported by local media. The clinic ... The clinic's closure follows a 90-day freeze on US foreign aid, which includes ...